<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38978145</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>09</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>11</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-1315</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>08</Day></PubDate></JournalIssue><Title>Journal of health, population, and nutrition</Title><ISOAbbreviation>J Health Popul Nutr</ISOAbbreviation></Journal><ArticleTitle>Epidemiological characteristics of first-time SARS-CoV-2 Omicron infection among hospital staff in Chengdu, China.</ArticleTitle><Pagination><StartPage>104</StartPage><MedlinePgn>104</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">104</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s41043-024-00595-3</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">After China ended its 'dynamic zero-COVID policy' on 7 December 2022, a large-scale outbreak of SARS-CoV-2 Omicron infections emerged across the country. We conducted a hospital-wide prospective study to document the epidemiological characteristics of the outbreak among healthcare workers in a hospital of Chengdu, where no previous staff SARS-CoV-2 infections were detected.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">All hospital staff members were invited to complete an online questionnaire on COVID-19 in January 2023, and SARS-CoV-2 infection cases were followed up by telephone in June 2023 to collect data on long COVID. Univariable and multivariable logistic regression analyses were performed to evaluate factors associated with SARS-CoV-2 infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2,899 hospital staff (93.5%) completed the online questionnaire, and 86.4% were infected with SARS-CoV-2 Omicron. The clinical manifestations of these patients were characterized by a high incidence of systemic symptoms. Cough (83.4%), fatigue (79.8%) and fever (74.3%) were the most frequently reported symptoms. Multivariable logistic analysis revealed that females [adjusted odds ratio (aOR): 1.42, 95% confidence interval (CI): 1.07-1.88] and clinical practitioners (aOR: 10.32, 95% CI: 6.57-16.20) were associated with an increased risk of SARS-CoV-2 infection, whereas advanced age&#x2009;&#x2265;&#x2009;60 years (aOR: 0.30, 95% CI: 0.19-0.49) and a three-dose COVID-19 vaccination with the most recent dose administered within 3 months before 7 December 2022 (aOR: 0.44, 95% CI: 0.23-0.87 for within 1 month; aOR: 0.46, 95% CI: 0.22-0.97 for within 1-3 months) were associated with reduced risk. Among the cases, 4.27% experienced long COVID of fatigue, brain fog or both, with the majority reporting minor symptoms.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our findings provide a snapshot of the epidemiological situation of SARS-CoV-2 infection among healthcare workers in Chengdu after China's deregulation of COVID-19 control. Data in the study can aid in the development and implementation of effective measures to protect healthcare workers and maintain the integrity of healthcare systems during challenging times such as a rapid and widespread Omicron outbreak.</AbstractText><CopyrightInformation>&#xa9; 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Tang</LastName><ForeName>Li</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Wang</LastName><ForeName>Yeyuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Xue</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Liu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luo</LastName><ForeName>Yingjuan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Chunrong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Yulei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 611731, China. 48533259@qq.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>Bangladesh</Country><MedlineTA>J Health Popul Nutr</MedlineTA><NlmUniqueID>100959228</NlmUniqueID><ISSNLinking>1606-0997</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086663">COVID-19 Vaccines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010564" MajorTopicYN="N">Personnel, Hospital</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015994" MajorTopicYN="N">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="N">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086663" MajorTopicYN="N">COVID-19 Vaccines</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Associated factors</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">China</Keyword><Keyword MajorTopicYN="N">Incidence</Keyword><Keyword MajorTopicYN="N">Omicron</Keyword><Keyword MajorTopicYN="N">Symptoms</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>7</Month><Day>9</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>7</Month><Day>8</Day><Hour>23</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>8</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38978145</ArticleId><ArticleId IdType="pmc">PMC11232323</ArticleId><ArticleId IdType="doi">10.1186/s41043-024-00595-3</ArticleId><ArticleId IdType="pii">10.1186/s41043-024-00595-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Carabelli AM, Peacock TP, Thorne LG, Harvey WT, Hughes J, Peacock SJ, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol. 2023;21(3):162&#x2013;77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Karim SSA, Karim QA. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Lancet. 2021;398(10317):2126&#x2013;8. doi: 10.1016/S0140-6736(21)02758-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02758-6</ArticleId><ArticleId IdType="pmc">PMC8640673</ArticleId><ArticleId IdType="pubmed">34871545</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Statement on the update of WHO&#x2019;s working definitions and tracking system for SARS-CoV-2 variants of concern and variants of interest 2023. https://www.who.int/news/item/16-03-2023-statement-on-the-update-of-who-s-working-definitions-and-tracking-system-for-sars-cov-2-variants-of-concern-and-variants-of-interest</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10153606</ArticleId><ArticleId IdType="pubmed">37062542</ArticleId></ArticleIdList></Reference><Reference><Citation>National Health Commission of the People&#x2019;s Republic of China. A circular on further optimizing the COVID-19 control policies. Beijing. 2022. http://www.nhc.gov.cn/xcs/gzzcwj/202212/8278e7a7aee34e5bb378f0e0fc94e0f0.shtml. [in Chinese].</Citation></Reference><Reference><Citation>Yang J, Hong W, Lei H, He C, Lei W, Zhou Y, et al. Low levels of neutralizing antibodies against XBB Omicron subvariants after BA.5 infection. Signal Transduct Target Ther. 2023;8(1):252. doi: 10.1038/s41392-023-01495-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01495-4</ArticleId><ArticleId IdType="pmc">PMC10279763</ArticleId><ArticleId IdType="pubmed">37336889</ArticleId></ArticleIdList></Reference><Reference><Citation>Yahemba D, Chowdhury S, Olorunfemi T, Dubukumah L, David A, Umunnakwe C, et al. Exploring the impact of COVID-19 on frontline health workers through a photovoice study in Kaduna, Kwara and Ogun States, Nigeria. Int Health. 2023;15(Suppl 1):i110&#x2013;25. doi: 10.1093/inthealth/ihad005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/inthealth/ihad005</ArticleId><ArticleId IdType="pmc">PMC10037267</ArticleId><ArticleId IdType="pubmed">36960811</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrett ES, Horton DB, Roy J, Gennaro ML, Brooks A, Tischfield J, et al. Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic. BMC Infect Dis. 2020;20(1):853. doi: 10.1186/s12879-020-05587-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-020-05587-2</ArticleId><ArticleId IdType="pmc">PMC7668027</ArticleId><ArticleId IdType="pubmed">33198725</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong SC, Chan VW, Yuen LL, AuYeung CH, Leung JO, Li CK, et al. Infection of healthcare workers despite a high vaccination rate during the fifth wave of COVID-19 due to Omicron variant in Hong Kong. Infect Prev Pract. 2023;5(1):100261. doi: 10.1016/j.infpip.2022.100261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.infpip.2022.100261</ArticleId><ArticleId IdType="pmc">PMC9705264</ArticleId><ArticleId IdType="pubmed">36465098</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheng WH, Chang HC, Chang SY, Hsieh MJ, Chen YC, Wu YY, et al. SARS-CoV-2 infection among healthcare workers whom already received booster vaccination during epidemic outbreak of omicron variant in Taiwan. J Formos Med Assoc. 2023;122(5):376&#x2013;83. doi: 10.1016/j.jfma.2022.12.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2022.12.003</ArticleId><ArticleId IdType="pmc">PMC9755014</ArticleId><ArticleId IdType="pubmed">36564300</ArticleId></ArticleIdList></Reference><Reference><Citation>Dzinamarira T, Nkambule SJ, Hlongwa M, Mhango M, Iradukunda PG, Chitungo I, et al. Risk factors for COVID-19 infection among Healthcare Workers. A First Report from a living systematic review and meta-analysis. Saf Health Work. 2022;13(3):263&#x2013;8. doi: 10.1016/j.shaw.2022.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.shaw.2022.04.001</ArticleId><ArticleId IdType="pmc">PMC9004144</ArticleId><ArticleId IdType="pubmed">35433073</ArticleId></ArticleIdList></Reference><Reference><Citation>Pouquet M, Decarreaux D, Di Domenico L, Sabbatini CE, Pr&#xe9;vot-Monsacre P, Fouri&#xe9; T, et al. SARS-CoV-2 infection prevalence and associated factors among primary healthcare workers in France after the third COVID-19 wave. Sci Rep. 2024;14(1):5418. doi: 10.1038/s41598-024-55477-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-024-55477-9</ArticleId><ArticleId IdType="pmc">PMC10914718</ArticleId><ArticleId IdType="pubmed">38443618</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Marron L, O&#x2019;Brien K, Walsh C, Domegan L, McGrath J, et al. Investigating incidence of and factors associated with SARS-CoV-2 infection over a nine-month period in a highly-vaccinated healthcare worker cohort. QJM. 2024 doi: 10.1093/qjmed/hcae093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcae093</ArticleId><ArticleId IdType="pubmed">38759112</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruickshank M, Brazzelli M, Manson P, Torrance N, Grant A. What is the impact of long-term COVID-19 on workers in healthcare settings? A rapid systematic review of current evidence. PLoS ONE. 2024;19(3):e0299743. doi: 10.1371/journal.pone.0299743.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0299743</ArticleId><ArticleId IdType="pmc">PMC10914278</ArticleId><ArticleId IdType="pubmed">38442116</ArticleId></ArticleIdList></Reference><Reference><Citation>Marra AR, Sampaio VS, Ozahata MC, Lopes R, Brito AF, Bragatte M, et al. Risk factors for long coronavirus disease 2019 (long COVID) among healthcare personnel, Brazil, 2020&#x2013;2022. Infect Control Hosp Epidemiol. 2023;44(12):1972&#x2013;8. doi: 10.1017/ice.2023.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/ice.2023.95</ArticleId><ArticleId IdType="pmc">PMC10755155</ArticleId><ArticleId IdType="pubmed">37272468</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C, Valdes AM, Polidori L, Antonelli M, Penamakuri S, Nogal A, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022;399(10335):1618&#x2013;24. doi: 10.1016/S0140-6736(22)00327-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00327-0</ArticleId><ArticleId IdType="pmc">PMC8989396</ArticleId><ArticleId IdType="pubmed">35397851</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes SE, Haroon S, Subramanian A, McMullan C, Aiyegbusi OL, Turner GM, et al. Development and validation of the symptom burden questionnaire for long covid (SBQ-LC): Rasch analysis. BMJ. 2022;377:e070230. doi: 10.1136/bmj-2022-070230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2022-070230</ArticleId><ArticleId IdType="pmc">PMC9043395</ArticleId><ArticleId IdType="pubmed">35477524</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Post COVID-19 condition (Long COVID) 2022. https://www.who.int/europe/news-room/fact-sheets/item/post-covid-19-condition</Citation></Reference><Reference><Citation>Liu R, Zhang Y, Ma J, Wang H, Lan Y, Tang X. Epidemiological features of SARS-CoV-2 Omicron infection under new control strategy: a cross-sectional study of the outbreak since December 2022 in Sichuan, China. BMC Public Health. 2023;23(1):2463. doi: 10.1186/s12889-023-17361-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-023-17361-5</ArticleId><ArticleId IdType="pmc">PMC10709916</ArticleId><ArticleId IdType="pubmed">38066518</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizoue T, Yamamoto S, Oshiro Y, Inamura N, Nemoto T, Horii K, et al. Cumulative and undiagnosed SARS-CoV-2 infection among the staff of a medical research centre in Tokyo after the emergence of variants. Epidemiol Infect. 2023;151:e48. doi: 10.1017/S0950268823000353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0950268823000353</ArticleId><ArticleId IdType="pmc">PMC10063865</ArticleId><ArticleId IdType="pubmed">36960731</ArticleId></ArticleIdList></Reference><Reference><Citation>Valderrama-Beltr&#xe1;n SL, Cuervo-Rojas J, Ariza B, Cardozo C, &#xc1;ngel J, Martinez-Vernaza S, et al. Cumulative incidence, prevalence, seroconversion, and associated factors for SARS-CoV-2 infection among healthcare workers of a University Hospital in Bogot&#xe1;, Colombia. PLoS ONE. 2022;17(9):e0274484. doi: 10.1371/journal.pone.0274484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0274484</ArticleId><ArticleId IdType="pmc">PMC9484677</ArticleId><ArticleId IdType="pubmed">36121816</ArticleId></ArticleIdList></Reference><Reference><Citation>Stead D, Adeniyi OV, Singata-Madliki M, Abrahams S, Batting J, Jelliman E, et al. Cumulative incidence of SARS-CoV-2 and associated risk factors among healthcare workers: a cross-sectional study in the Eastern Cape, South Africa. BMJ Open. 2022;12(3):e058761. doi: 10.1136/bmjopen-2021-058761.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-058761</ArticleId><ArticleId IdType="pmc">PMC8935006</ArticleId><ArticleId IdType="pubmed">35304402</ArticleId></ArticleIdList></Reference><Reference><Citation>Platten M, Nienhaus A, Peters C, Cranen R, Wisplinghoff H, Kersten JF, et al. Cumulative incidence of SARS-CoV-2 in Healthcare Workers at a General Hospital in Germany during the Pandemic-A longitudinal analysis. Int J Environ Res Public Health. 2022;19(4):2429. doi: 10.3390/ijerph19042429.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph19042429</ArticleId><ArticleId IdType="pmc">PMC8872027</ArticleId><ArticleId IdType="pubmed">35206616</ArticleId></ArticleIdList></Reference><Reference><Citation>Nisha B, Dakshinamoorthy K, Padmanaban P, Jain T, Neelavarnan M. Infection, reinfection, and postvaccination incidence of SARS-CoV-2 and associated risks in healthcare workers in Tamil Nadu: a retrospective cohort study. J Family Community Med. 2022;29(1):49&#x2013;55. doi: 10.4103/jfcm.jfcm_399_21.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jfcm.jfcm_399_21</ArticleId><ArticleId IdType="pmc">PMC8802725</ArticleId><ArticleId IdType="pubmed">35197728</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu S, Zong Z. Why did so few healthcare workers in China get COVID-19 infection. QJM. 2021;114(4):225&#x2013;6. doi: 10.1093/qjmed/hcaa254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcaa254</ArticleId><ArticleId IdType="pmc">PMC7454915</ArticleId><ArticleId IdType="pubmed">32810218</ArticleId></ArticleIdList></Reference><Reference><Citation>China Center for Disease Control and Prevention. COVID-19 clinical and surveillance data &#x2013; December 9, 2022 to January 23, 2023, China. 2023. https://en.chinacdc.cn/news/latest/202301/W020230126558725888448.pdf</Citation></Reference><Reference><Citation>Nakakubo S, Kishida N, Okuda K, Kamada K, Iwama M, Suzuki M, et al. Associations of COVID-19 symptoms with omicron subvariants BA.2 and BA.5, host status, and clinical outcomes in Japan: a registry-based observational study. Lancet Infect Dis. 2023;23(11):1244&#x2013;56. doi: 10.1016/S1473-3099(23)00271-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00271-2</ArticleId><ArticleId IdType="pmc">PMC10615696</ArticleId><ArticleId IdType="pubmed">37399831</ArticleId></ArticleIdList></Reference><Reference><Citation>Arabi M, Al-Najjar Y, Sharma O, Kamal I, Javed A, Gohil HS, et al. Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review. BMC Infect Dis. 2023;23(1):432. doi: 10.1186/s12879-023-08328-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-023-08328-3</ArticleId><ArticleId IdType="pmc">PMC10294418</ArticleId><ArticleId IdType="pubmed">37365490</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Chen M, Chen Q, Zhang T, Xu B, Tung TH, et al. Assessment of the risk and symptoms of SARS-CoV-2 infection among Healthcare workers during the Omicron Transmission Period: a multicentric study from four hospitals of Mainland China. Infect Drug Resist. 2023;16:3315&#x2013;28. doi: 10.2147/IDR.S412657.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S412657</ArticleId><ArticleId IdType="pmc">PMC10237192</ArticleId><ArticleId IdType="pubmed">37274362</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosino I, Barbagelata E, Ortona E, Ruggieri A, Massiah G, Giannico OV, et al. Gender differences in patients with COVID-19: a narrative review. Monaldi Arch Chest Dis. 2020;90(2). 10.4081/monaldi.2020.1389</Citation><ArticleIdList><ArticleId IdType="pubmed">32449614</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C, Qian Y. The gender peak effect: women are most vulnerable to infections during COVID-19 peaks. Front Public Health. 2022;10:937179. doi: 10.3389/fpubh.2022.937179.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2022.937179</ArticleId><ArticleId IdType="pmc">PMC9395988</ArticleId><ArticleId IdType="pubmed">36016899</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020;11(1):29. doi: 10.1186/s13293-020-00304-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-020-00304-9</ArticleId><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Noel L, Marion E, Boufercha R, Martin F, Zandotti C, Charrel R, et al. Screening of health workers exposed to SARS-CoV-2 in a university hospital in the south of France. Int Arch Occup Environ Health. 2022;95(2):419&#x2013;24. doi: 10.1007/s00420-021-01789-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00420-021-01789-6</ArticleId><ArticleId IdType="pmc">PMC8519329</ArticleId><ArticleId IdType="pubmed">34654945</ArticleId></ArticleIdList></Reference><Reference><Citation>Oda G, Sharma A, Lucero-Obusan C, Schirmer P, Sohoni P, Holodniy M. COVID-19 infections among Healthcare Personnel in the United States Veterans Health Administration, March to August, 2020. J Occup Environ Med. 2021;63(4):291&#x2013;5. doi: 10.1097/JOM.0000000000002109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/JOM.0000000000002109</ArticleId><ArticleId IdType="pubmed">33315723</ArticleId></ArticleIdList></Reference><Reference><Citation>Yanez ND, Weiss NS, Romand JA, Treggiari MM. COVID-19 mortality risk for older men and women. BMC Public Health. 2020;20(1):1742. doi: 10.1186/s12889-020-09826-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12889-020-09826-8</ArticleId><ArticleId IdType="pmc">PMC7675386</ArticleId><ArticleId IdType="pubmed">33213391</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process 2023. https://extranet.who.int/prequal/sites/default/files/document_files/Status_COVID_VAX_08AUgust2023.pdf</Citation></Reference><Reference><Citation>Luo D, Mei B, Wang P, Li X, Chen X, Wei G, et al. Prevalence and risk factors for persistent symptoms after COVID-19: a systematic review and meta-analysis. Clin Microbiol Infect. 2024;31(3):328&#x2013;35. doi: 10.1016/j.cmi.2023.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2023.10.016</ArticleId><ArticleId IdType="pubmed">37866679</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J, Lin K, Zhang H, Xue Q, Zhu K, Yuan G, et al. A one-year follow-up study of systematic impact of long COVID symptoms among patients post SARS-CoV-2 omicron variants infection in Shanghai, China. Emerg Microbes Infect. 2023;12(2):2220578. doi: 10.1080/22221751.2023.2220578.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2023.2220578</ArticleId><ArticleId IdType="pmc">PMC10281439</ArticleId><ArticleId IdType="pubmed">37272336</ArticleId></ArticleIdList></Reference><Reference><Citation>Shukla AK, Atal S, Banerjee A, Jhaj R, Balakrishnan S, Chugh PK, et al. An observational multi-centric COVID-19 sequelae study among health care workers. Lancet Reg Health Southeast Asia. 2023;10:100129. doi: 10.1016/j.lansea.2022.100129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lansea.2022.100129</ArticleId><ArticleId IdType="pmc">PMC9744681</ArticleId><ArticleId IdType="pubmed">36531928</ArticleId></ArticleIdList></Reference><Reference><Citation>Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023;2(1):e000385. doi: 10.1136/bmjmed-2022-000385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000385</ArticleId><ArticleId IdType="pmc">PMC9978692</ArticleId><ArticleId IdType="pubmed">36936268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>